Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Common Equity (2016 - 2025)

Xtant Medical Holdings has reported Common Equity over the past 16 years, most recently at $51.0 million for Q4 2025.

  • Quarterly Common Equity rose 18.6% to $51.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.0 million through Dec 2025, up 18.6% year-over-year, with the annual reading at $51.0 million for FY2025, 18.6% up from the prior year.
  • Common Equity was $51.0 million for Q4 2025 at Xtant Medical Holdings, up from $50.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $54.7 million in Q3 2023 and troughed at $28.1 million in Q2 2022.
  • The 5-year median for Common Equity is $38.6 million (2022), against an average of $40.0 million.
  • The largest YoY upside for Common Equity was 172.31% in 2021 against a maximum downside of 31.98% in 2021.
  • A 5-year view of Common Equity shows it stood at $30.9 million in 2021, then grew by 10.65% to $34.2 million in 2022, then surged by 50.27% to $51.3 million in 2023, then fell by 16.33% to $43.0 million in 2024, then increased by 18.6% to $51.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Common Equity are $51.0 million (Q4 2025), $50.4 million (Q3 2025), and $48.5 million (Q2 2025).